Successful management of anti-MDA5-positive rapidly progressive interstitial lung disease-A case series

被引：5

作者：

Tseng, Chih-Wei ^{[1
,2
,3
]}

机构：

[1] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan

[2] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan

[3] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, 1650 Taiwan Blvd Sect 4, Taichung 40705, Taiwan

来源：

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2023年 / 26卷 / 05期

关键词：

melanoma differentiation-associated protein 5; prophylaxis; rapidly progressive interstitial lung disease; DERMATOMYOSITIS;

D O I：

10.1111/1756-185X.14563

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：992 / 995

页数：4

共 6 条

[1] Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease [J].

Chen, Zhiwei ;

Wang, Xiaodong ;

Ye, Shuang .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03) :291-293

[2] 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease [J].

Kondoh, Yasuhiro ;

Makino, Shigeki ;

Ogura, Takashi ;

Suda, Takafumi ;

Tomioka, Hiromi ;

Amano, Hirofumi ;

Anraku, Masaki ;

Enomoto, Noriyuki ;

Fujii, Takao ;

Fujisawa, Tomoyuki ;

Gono, Takahisa ;

Harigai, Masayoshi ;

Ichiyasu, Hidenori ;

Inoue, Yoshikazu ;

Johkoh, Takeshi ;

Kameda, Hideto ;

Kataoka, Kensuke ;

Katsumata, Yasuhiro ;

Kawaguchi, Yasushi ;

Kawakami, Atsushi ;

Kitamura, Hideya ;

Kitamura, Noboru ;

Koga, Tomohiro ;

Kurasawa, Kazuhiro ;

Nakamura, Yutaro ;

Nakashima, Ran ;

Nishioka, Yasuhiko ;

Nishiyama, Osamu ;

Okamoto, Masaki ;

Sakai, Fumikazu ;

Sakamoto, Susumu ;

Sato, Shinji ;

Shimizu, Toshimasa ;

Takayanagi, Noboru ;

Takei, Reoto ;

Takemura, Tamiko ;

Takeuchi, Tohru ;

Toyoda, Yuko ;

Yamada, Hidehiro ;

Yamakawa, Hideaki ;

Yamano, Yasuhiko ;

Yamasaki, Yoshioki ;

Kuwana, Masataka .

RESPIRATORY INVESTIGATION, 2021, 59 (06) :709-740

[3] Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis [J].

Kurasawa, Kazuhiro ;

Arai, Satoko ;

Namiki, Yumeko ;

Tanaka, Ayae ;

Takamura, Yuta ;

Owada, Takayoshi ;

Arima, Masafumi ;

Maezawa, Reika .

RHEUMATOLOGY, 2018, 57 (12) :2114-2119

[4] GAP Score and CA-153 Associated with One-Year Mortality in Anti-MDA-5 Antibody-Positive Patients: A Real-World Experience [J].

Tseng, Chih-Wei ;

Wang, Kao-Lun ;

Fu, Pin-Kuei ;

Huang, Cheng-Yi ;

Hsieh, Tsu-Yi ;

Hsieh, Chia-Wei ;

Lai, Kuo-Lung ;

Hung, Wei-Ting ;

Lin, Ching-Tsai ;

Tang, Kuo-Tung ;

Chen, Yi-Ming ;

Huang, Wen-Nan ;

Chen, Yi-Hsing .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)

[5] Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study [J].

Wu, Wanlong ;

Xu, Wenwen ;

Sun, Wenjia ;

Zhang, Danting ;

Zhao, Jiangfeng ;

Luo, Qun ;

Wang, Xiaodong ;

Zhu, Feng ;

Zheng, Yu ;

Xue, Yu ;

Wan, Weiguo ;

Wu, Huaxiang ;

Han, Qian ;

Ye, Shuang .

RHEUMATOLOGY, 2022, 61 (01) :230-239

[6] Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report [J].

Yen, Tsai-Hung ;

Tseng, Chih-Wei ;

Wang, Kao-Lun ;

Fu, Pin-Kuei .

MEDICINA-LITHUANIA, 2021, 57 (12)

← 1 →